Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
5 "Soo Teik Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Statement
Cancer
Clinical practice guideline for endoscopic resection of early gastrointestinal cancer
Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong Yeul Lee, Jeong-Sik Byeon, Chan Guk Park, Joo Young Cho, Soo Teik Lee, Hoon Jai Chun
Intest Res 2021;19(2):127-157.   Published online October 13, 2020
DOI: https://doi.org/10.5217/ir.2020.00020
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Although surgery was the standard treatment for early gastrointestinal cancers, endoscopic resection is now a standard treatment for early gastrointestinal cancers without regional lymph node metastasis. High-definition white light endoscopy, chromoendoscopy, and image-enhanced endoscopy such as narrow band imaging are performed to assess the edge and depth of early gastrointestinal cancers for delineation of resection boundaries and prediction of the possibility of lymph node metastasis before the decision of endoscopic resection. Endoscopic mucosal resection and/or endoscopic submucosal dissection can be performed to remove early gastrointestinal cancers completely by en bloc fashion. Histopathological evaluation should be carefully made to investigate the presence of risk factors for lymph node metastasis such as depth of cancer invasion and lymphovascular invasion. Additional treatment such as radical surgery with regional lymphadenectomy should be considered if the endoscopically resected specimen shows risk factors for lymph node metastasis. This is the first Korean clinical practice guideline for endoscopic resection of early gastrointestinal cancer. This guideline was developed by using mainly de novo methods and encompasses endoscopic management of superficial esophageal squamous cell carcinoma, early gastric cancer, and early colorectal cancer. This guideline will be revised as new data on early gastrointestinal cancer are collected.

Citations

Citations to this article as recorded by  
  • Distinct genomic, transcriptomic, and immune profiles for tumor and non-tumor mucosal regions in early gastric cancer
    You Jeong Heo, Soomin Ahn, So Young Kang, Hyunjin Kim, Byung-Hoon Min, Kyoung-Mee Kim
    Pathology - Research and Practice.2025; 266: 155768.     CrossRef
  • Risk factors and predictive nomogram for non-curative resection in patients with early gastric cancer treated with endoscopic submucosal dissection: a retrospective cohort study
    Lihua Guo, Yong Ding, Jinfeng Wen, Min Miao, Kefeng Hu, Guoliang Ye
    World Journal of Surgical Oncology.2025;[Epub]     CrossRef
  • Endoscopic submucosal dissection for superficial ultra-low rectal tumors: outcomes and predictive factors for procedure difficulty
    Yinxin Wu
    American Journal of Cancer Research.2024; 14(12): 5784.     CrossRef
  • A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer
    Zhenghua Piao, Rong Ge, Chunnian Wang
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area
    Valli De Re, Stefano Realdon, Roberto Vettori, Alice Zaramella, Stefania Maiero, Ombretta Repetto, Vincenzo Canzonieri, Agostino Steffan, Renato Cannizzaro
    International Journal of Molecular Sciences.2023; 24(4): 3290.     CrossRef
  • Chasm between Public Perceptions and Epidemiological Data on Colorectal Cancer
    Su Bee Park, Min Seob Kwak, Jin Young Yoon, Jae Myung Cha
    Gut and Liver.2023; 17(3): 449.     CrossRef
  • Calcium, Vitamin D, and Colorectal Cancer
    Young-Jo Wi, Soo-Young Na
    The Korean Journal of Gastroenterology.2023; 82(2): 47.     CrossRef
  • Effectiveness and Safety of Endoscopic Submucosal Dissection for Colorectal Neoplasm in Patients with High Charlson Comorbidity Index Score: A HASID Multicenter Study
    Dong-Hyun Kim, Yong-Wook Jung, Byung-Chul Jin, Hyung-Hoon Oh, Hyo-Yeop Song, Seong-Jung Kim, Dae-Seong Myung, Sang-Wook Kim, Jun Lee, Geom-Seog Seo, Young-Eun Joo, Hyun-Soo Kim
    Journal of Clinical Medicine.2023; 12(19): 6255.     CrossRef
  • Endoscopic management of pseudo-lumen stapling following laparoscopic esophagojejunostomy: A case report
    Seung Soo Lee
    International Journal of Surgery Case Reports.2023; 111: 108830.     CrossRef
  • Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis
    Jihun Jang, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
    Intestinal Research.2023; 21(4): 510.     CrossRef
  • Summary and comparison of recently updated post-polypectomy surveillance guidelines
    Yoon Suk Jung
    Intestinal Research.2023; 21(4): 443.     CrossRef
  • Advanced Endoscopic Resection Techniques in Cirrhosis—A Systematic Review and Meta-Analysis of Outcomes
    Saurabh Chandan, Smit Deliwala, Shahab R. Khan, Daryl Ramai, Babu P. Mohan, Mohammad Bilal, Antonio Facciorusso, Lena L. Kassab, Faisal Kamal, Banreet Dhindsa, Abhilash Perisetti, Douglas G. Adler
    Digestive Diseases and Sciences.2022; 67(10): 4813.     CrossRef
  • Prognosis and risk factors of electrocoagulation syndrome after endoscopic submucosal dissection in the colon and rectum. Large cohort study
    Seong-Jung Kim, Su Young Kim, Jun Lee
    Surgical Endoscopy.2022; 36(8): 6243.     CrossRef
  • Comparison between Endoscopic Submucosal Dissection and Surgery in Patients with Early Gastric Cancer
    Meng Qian, Yuan Sheng, Min Wu, Song Wang, Kaiguang Zhang
    Cancers.2022; 14(15): 3603.     CrossRef
  • Endoscopic methods for the detection and treatment of gastric cancer
    Negar Niknam, Steven Obanor, Linda A. Lee
    Current Opinion in Gastroenterology.2022; 38(5): 436.     CrossRef
  • Association Between Family History of Gastric Cancer and the Risk of Gastric Cancer and Adenoma: A Nationwide Population-Based Study
    Yoon Suk Jung, Mai Thi Xuan Tran, Boyoung Park, Chang Mo Moon
    American Journal of Gastroenterology.2022; 117(8): 1255.     CrossRef
  • Colonic Chicken Skin Mucosa Surrounding Colon Polyps Is an Endoscopic Predictive Marker for Colonic Neoplastic Polyps
    Yu Mi Lee, Kyung Ho Song, Hoon Sup Koo, Choong-Sik Lee, Inseok Ko, Sang Hyuk Lee, Kyu Chan Huh
    Gut and Liver.2022; 16(5): 754.     CrossRef
  • Artificial intelligence-based colorectal polyp histology prediction using narrow-band image-magnifying colonoscopy: a stepping stone for clinical practice
    Ji Young Chang
    Clinical Endoscopy.2022; 55(5): 699.     CrossRef
  • Feasibility of same-day discharge following endoscopic submucosal dissection for esophageal or gastric early cancer
    Jing Wang, Shi-Jie Li, Yan Yan, Peng Yuan, Wei-Feng Li, Chang-Qi Cao, Wei-Gang Chen, Ke-Neng Chen, Qi Wu
    World Journal of Gastroenterology.2022; 28(41): 5957.     CrossRef
  • Endoscopic, clinicopathological, and growth characteristics of minute gastric cancer
    Zhu Hui Liu, Shi Yuan Lu, Xiao Bo Li, Hui Min Chen, Hao Yan Chen, Xiao Yu Chen, Jing‐Yuan Fang, Yun Cui
    Journal of Digestive Diseases.2022; 23(11): 628.     CrossRef
  • Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer
    Darina Kohoutova, Matthew Banks, Jan Bures
    Cancers.2021; 13(24): 6242.     CrossRef
  • 9,908 View
  • 279 Download
  • 25 Web of Science
  • 21 Crossref
Close layer
Original Article
Colorectal neoplasia
Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
Shi Mao Zhu, Yong Ran Park, Seung Yong Seo, In Hee Kim, Soo Teik Lee, Sang Wook Kim
Intest Res 2019;17(4):527-536.   Published online August 23, 2019
DOI: https://doi.org/10.5217/ir.2019.00031
AbstractAbstract PDFPubReaderePub
Background/Aims
Transforming growth factor-β1 (TGF-β1) induction of epithelial-mesenchymal transition (EMT) is one of the mechanisms by which colorectal cancer (CRC) cells acquire migratory and invasive capacities, and subsequently metastasize. Parthenolide (PT) expresses multiple anti-cancer and anti-inflammatory activities that inhibit nuclear factor κB by targeting the IκB kinase complex. In the present study, we aimed to investigate whether PT can inhibit TGF-β1-induced EMT in CRC cell lines.
Methods
HT-29 and SW480 cell lines were used in the experiment. Cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and sub-G1 analysis was measured by flow cytometry. The induction of EMT by TGF-β1 and inhibition of the process by PT was analyzed by phase contrast microscopy, wounding healing, cellular migration and invasion assays, and Western blotting.
Results
TGF-β1 inhibits HT-29 cell proliferation, but has no effect on SW480 cell proliferation; different concentrations of TGF-β1 did not induce apoptosis in HT-29 and SW480 cells. PT attenuates TGF-β1-induced elongated, fibroblast-like shape changing in cells. PT inhibits TGF-β1-induced cell migration and cell invasion. In addition, other EMT markers such as β-catenin, Vimentin, Snail, and Slug were suppressed by PT, while E-cadherin was increased by PT.
Conclusions
Our findings show that PT inhibits TGF-β1-induced EMT by suppressing the expression of the mesenchymal protein and increasing expression of the epithelial protein. These findings suggest a novel approach for CRC treatment by suppression of TGF-β1-induced EMT.

Citations

Citations to this article as recorded by  
  • Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural–Mesenchymal Transition
    Andrey V. Markov, Arseny D. Moralev, Kirill V. Odarenko
    Biomedicines.2025; 13(1): 133.     CrossRef
  • Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide
    Jian Li, Xin Li, Hongwei Liu
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Sesquiterpene Lactones as Promising Phytochemicals to Cease Metastatic Propagation of Cancer
    Fatemeh Mehdikhani, Homa Hajimehdipoor, Mojgan Tansaz, Marc Maresca, Sadegh Rajabi
    Biomolecules.2025; 15(2): 268.     CrossRef
  • Cumin (Cuminum cyminum L.) seeds accelerates wound healing in rats: Possible molecular mechanisms
    Khaled Abdul‐Aziz Ahmed, Ahmed A. J. Jabbar, Yaseen Galali, Ayman M. Al‐Qaaneh, Gökhan Akçakavak, Nur Ain Salehen, Rawaz Rizgar Hassan, Ramzi A. Mothana, Mahmood Ameen Abdulla, Omer I. Fantoukh, Sidig Hasson, Mohammed F. Hawwal
    Skin Research and Technology.2024;[Epub]     CrossRef
  • TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance
    Allan M. Johansen, Steven D. Forsythe, Callum T. McGrath, Grayson Barker, Hugo Jimenez, Ravi K. Paluri, Boris C. Pasche
    Clinical Cancer Research.2024; 30(17): 3676.     CrossRef
  • NF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets
    Ashkan Bahrami, Amirreza Khalaji, Majed Bahri Najafi, Sina Sadati, Arash Raisi, AmirMohammad Abolhassani, Reza Eshraghi, Mahmood Khaksary Mahabady, Neda Rahimian, Hamed Mirzaei
    European Journal of Medical Research.2024;[Epub]     CrossRef
  • Bitter taste signaling in cancer
    Ana R. Costa, Ana C. Duarte, Ana R. Costa-Brito, Isabel Gonçalves, Cecília R.A. Santos
    Life Sciences.2023; 315: 121363.     CrossRef
  • Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell–cell adhesion loss through downregulation of NF‐κB pathway TNF‐α‐activated in colorectal cancer cells
    Adriana S. Gehren, Waldemir F. de Souza, Annie C. M. Sousa‐Squiavinato, Diego A. A. Ramos, Bruno R. B. Pires, Eliana S. F. W. Abdelhay, Jose A. Morgado‐Diaz
    Cell Biology International.2023; 47(9): 1638.     CrossRef
  • Parthenolide repressed endometriosis induced surgically in rats: Role of PTEN/PI3Kinase/AKT/GSK-3β/β-catenin signaling in inhibition of epithelial mesenchymal transition
    Soad L. Kabil, Hayam E. Rashed, Noura Mostafa Mohamed, Nisreen E. Elwany
    Life Sciences.2023; 331: 122037.     CrossRef
  • TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer
    Sumeet Singh, Vinita Gouri, Mukesh Samant
    Medical Oncology.2023;[Epub]     CrossRef
  • The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
    Tao An, Huanhuan Yin, Yanting Lu, Feng Liu
    Drug Design, Development and Therapy.2022; Volume 16: 1255.     CrossRef
  • Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies
    Hazera Binte Sufian, Julianna Maria Santos, Zeina S. Khan, Sobia Ahsan Halim, Ajmal Khan, Maliha Tabassum Munir, MD Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
    Life Sciences.2022; 301: 120610.     CrossRef
  • Cinnamomum bejolghota Extract Inhibits Colorectal Cancer Cell Metastasis and TGF-β1-Induced Epithelial-Mesenchymal Transition via Smad and Non-Smad Signaling Pathway
    Athicha Kittiwattanokhun, Sukanda Innajak, Etsu Tashiro, Masaya Imoto, Ramida Watanapokasin
    Scientia Pharmaceutica.2022; 90(2): 30.     CrossRef
  • Autoimmunity and Cancer—Two Sides of the Same Coin
    Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, Ines Papak, Aleksandra Markiewicz, Katarzyna Dziubek, Małgorzata Kurkowiak, Sachin Kote, Karolina Kaźmierczak-Siedlecka, Karol Połom, Natalia Marek-Trzonkowska, Piotr Trzonkowski
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Sesquiterpene Lactones and Cancer: New Insight into Antitumor and Anti-inflammatory Effects of Parthenolide-Derived Dimethylaminomicheliolide and Micheliolide
    Yubo Dong, Xuanjin Qian, Jian Li, Ahmed Faeq Hussein
    Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
  • Plants as a Source of Anticancer Agents: From Bench to Bedside
    Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, Reem Ali Hamed, Dima Awajan, Sara Feras Abuarab, Lena Hisham Odeh, Samar Khater, Lina T. Al Kury
    Molecules.2022; 27(15): 4818.     CrossRef
  • Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer
    Nima Zafari, Mahla Velayati, Mohammadreza Nassiri, Majid Khazaei, Seyed Mahdi Hassanian, Gordon A. Ferns, Amir Avan
    Current Pharmaceutical Design.2022; 28(28): 2298.     CrossRef
  • The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities
    Rubén Varela‐Calviño, Marta Rodríguez‐Quiroga, Patrícia Dias Carvalho, Flavia Martins, André Serra‐Roma, Lorena Vázquez‐Iglesias, María Páez de la Cadena, Sérgia Velho, Oscar J. Cordero
    IUBMB Life.2021; 73(5): 761.     CrossRef
  • Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF


    Bo Tian, Yuhang Xiao, Junliang Ma, Wei Ou, Hui Wang, Jie Wu, Jinming Tang, Baihua Zhang, Xiaojuan Liao, Desong Yang, Zhining Wu, Xu Li, Yong Zhou, Min Su, Wenxiang Wang
    OncoTargets and Therapy.2020; Volume 13: 7447.     CrossRef
  • Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity
    Alex S. Quy, Xingjian Li, Louise Male, Tatjana Stankovic, Angelo Agathanggelou, John S. Fossey
    Tetrahedron.2020; : 131631.     CrossRef
  • Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
    Chang Hoon Lee
    Cancers.2019; 11(12): 1841.     CrossRef
  • 9,345 View
  • 188 Download
  • 23 Web of Science
  • 21 Crossref
Close layer
Case Report
High grade anorectal stricture complicating Crohn's disease: endoscopic treatment using insulated-tip knife
Hyung Ku Chon, Ik Sang Shin, Sang Wook Kim, Soo Teik Lee
Intest Res 2016;14(3):285-288.   Published online June 27, 2016
DOI: https://doi.org/10.5217/ir.2016.14.3.285
AbstractAbstract PDFPubReaderePub

Endoscopic treatments have emerged as an alternative to surgery, in the treatment of benign colorectal stricture. Unlike endoscopic balloon dilatation, there is limited data on endoscopic electrocautery incision therapy for benign colorectal stricture, especially with regards to safety and long-term patency. We present a case of a 29-year-old female with Crohn's disease who had difficulty in defecation and passing thin stools. A pelvic magnetic resonance imaging scan, gastrograffin enema, and sigmoidoscopy showed a high-grade anorectal stricture. An endoscopic insulated-tip knife incision was successfully performed to resolve the problem. From our experience, we suggest that endoscopic insulated-tip knife treatment may be a feasible and effective modality for patients with short-segment, very rigid, fibrotic anorectal stricture.

Citations

Citations to this article as recorded by  
  • Development and psychometric validation of a patient-reported outcome measure scale for Crohn’s disease anorectal stricture
    Jin-Rong Li, Bo-Lin Yang, Zhen-Xing Zhu, Yu-Xia Gong, Hao Wang, Yun-Fei Gu, Dan Zhang, Min-Min Xu, Feng Jiang, Jie Kong, Xiao-Peng Wang, Su Xu, Chen Wang, Peng Du, Jun Shen, Ren Mao, Jia Ke, Feng Tian, Wei-Ming Zhu, Ping Zhu
    Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
  • Insulated tip/needle-knife endoscopic stricturotomy is safe and effective for treatment of non-traversable anorectal strictures
    Koby Herman, Ravi P. Kiran, Bo Shen
    Endoscopy International Open.2024; 12(02): E231.     CrossRef
  • IT Knife-Assisted Balloon Stricturoplasty in a Patient With Crohn's Disease
    Kevin Singh, Amandeep Singh, Bo Shen
    ACG Case Reports Journal.2020; 7(9): e00457.     CrossRef
  • 5,288 View
  • 39 Download
  • 4 Web of Science
  • 3 Crossref
Close layer
Original Articles
Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
Intest Res 2015;13(3):233-241.   Published online June 9, 2015
DOI: https://doi.org/10.5217/ir.2015.13.3.233
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Balsalazide is an anti-inflammatory drug used in the treatment of inflammatory bowel disease. Balsalazide can reduce inflammatory responses via several mechanisms, including inhibition of nuclear factor-κB (NF-κB) activity. Parthenolide (PT) inhibits NF-κB and exerts promising anticancer effects by promoting apoptosis. The present investigated the antitumor effects of balsalazide, combined with PT, on NF-κB in a representative human colorectal carcinoma cell line, HCT116.

Methods

We counted cells and conducted annexin-V assays and cell cycle analysis to measure apoptotic cell death. Western blotting was used investigate the levels of proteins involved in apoptosis.

Results

PT and balsalazide produced synergistic anti-proliferative effects and induced apoptotic cell death. The combination of balsalazide and PT markedly suppressed nuclear translocation of the NF-κB p65 subunit and the phosphorylation of inhibitor of NF-κB. Moreover, PT and balsalazide dramatically enhanced NF-κB p65 phosphorylation. Apoptosis, through the mitochondrial pathway, was confirmed by detecting effects on Bcl-2 family members, cytochrome c release, and activation of caspase-3 and -8.

Conclusions

Combination treatment with PT and balsalazide may offer an effective strategy for the induction of apoptosis in HCT116 cells.

Citations

Citations to this article as recorded by  
  • Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
    Chin King Looi, Ling-Wei Hii, Felicia Fei-Lei Chung, Chun-Wai Mai, Wei-Meng Lim, Chee-Onn Leong
    Cancers.2021; 13(8): 1786.     CrossRef
  • Computational investigation of FDA approved drugs as selective PARP-1 inhibitors by targeting BRCT domain for cancer therapy
    Chandan Kumar, P.T.V. Lakshmi, Annamalai Arunachalam
    Journal of Molecular Graphics and Modelling.2021; 108: 107919.     CrossRef
  • Identification of Autophagy-Associated Biomarkers and Corresponding Regulatory Factors in the Progression of Colorectal Cancer
    Chunrui Zhang, Jing Jiang, Liqiang Wang, Liyu Zheng, Jiankai Xu, Xiaolin Qi, Huiying Huang, Jianping Lu, Kongning Li, Hong Wang
    Frontiers in Genetics.2020;[Epub]     CrossRef
  • Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
    Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
    Molecular Biology Reports.2020; 47(8): 5807.     CrossRef
  • Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
    Malgorzata Sztiller-Sikorska, Malgorzata Czyz
    Pharmaceuticals.2020; 13(8): 194.     CrossRef
  • Integration of genetic variants and gene network for drug repurposing in colorectal cancer
    Lalu Muhammad Irham, Henry Sung-Ching Wong, Wan-Hsuan Chou, Wirawan Adikusuma, Eko Mugiyanto, Wan-Chen Huang, Wei-Chiao Chang
    Pharmacological Research.2020; 161: 105203.     CrossRef
  • Synthesis of azo dyes possessing N-heterocycles and evaluation of their anticancer and antibacterial properties
    Zarrin Ghasemi, Sajjad Azizi, Roya Salehi, Hossein Samadi Kafil
    Monatshefte für Chemie - Chemical Monthly.2018; 149(1): 149.     CrossRef
  • Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway
    Xiao-he Li, Ting Xiao, Jia-huan Yang, Yuan Qin, Jing-jing Gao, Hui-juan Liu, Hong-gang Zhou
    Respiratory Research.2018;[Epub]     CrossRef
  • Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
    Eun-Kyung Kim, Jae Hee Cho, EuiJoo Kim, Yoon Jae Kim, Aamir Ahmad
    PLOS ONE.2017; 12(7): e0181183.     CrossRef
  • Dietary selenium protects adiponectin knockout mice against chronic inflammation induced colon cancer
    Arpit Saxena, Raja Fayad, Kamaljeet Kaur, Samantha Truman, Julian Greer, James A. Carson, Anindya Chanda
    Cancer Biology & Therapy.2017; 18(4): 257.     CrossRef
  • Sesquiterpene binding Gly-Leu-Ser/Lys-“co-adaptation pocket” to inhibit lung cancer cell epithelial-mesenchymal transition
    Xiao-Yu Ai, Heng Zhang, Shao-Yan Gao, Yuan Qin, Wei-Long Zhong, Ju Gu, Meng Li, Kai-Liang Qiao, Qin Tian, Zhan-Hong Cui, Jia-Huan Yang, Zhun Bi, Ting Xiao, Shuang Chen, Hui-Juan Liu, Hong-Gang Zhou, Tao Sun, Cheng Yang
    Oncotarget.2017; 8(41): 70192.     CrossRef
  • Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction
    Liang Chen, Ya-Qiong Xiong, Jing Xu, Ji-Peng Wang, Zi-Li Meng, Yong-Qing Hong
    Oncotarget.2017; 8(55): 93878.     CrossRef
  • Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway
    Xianjin Zhu, Yanfang Song, Conglian Wu, Chuxi Pan, Pingxia Lu, Meihua Wang, Peizheng Zheng, Rongfen Huo, Chenqing Zhang, Wanting Li, Yulin Lin, Yingping Cao, Ningli Li
    Scientific Reports.2016;[Epub]     CrossRef
  • 6,185 View
  • 44 Download
  • 14 Web of Science
  • 13 Crossref
Close layer
Synergistic Effect of Parthenolide in Combination with 5-Fluorouracil in SW480 Cells
Se-Lim Kim, Thu Trang Thi Kieu , Byung Jun Jeon, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
Intest Res 2012;10(4):357-364.   Published online October 31, 2012
DOI: https://doi.org/10.5217/ir.2012.10.4.357
AbstractAbstract PDF
Background/Aims
Parthenolide (PT) is responsible for the bioactivities of Feverfew. Besides its potent anti-inflammatory effect, this compound has recently been reported to induce apoptosis in cancer cells. Unfortunately, many of the therapies that use 5-fluorouracil (5-FU) alone or in combination with other agents are likely to become ineffective due to drug resistance. In the present study, we investigate the antitumor effect of PT combined with 5-FU on colorectal cancer cells. Methods: SW480 cell was employed as a representative of human colorectal carcinoma (CRC) cells. We performed MTT, annexin-V assay, and Hoechst 33258 staining to measure the synergistic effect. Western blotting was used to demonstrate apoptotic pathway. Results: Our result demonstrated that PT inhibited the viability of colorectal cancer cells and had synergistic anti-proliferation in combination with 5-FU. After combined treatment of 5-FU and PT, enhanced apoptotic cell death is observed using annexin-V FITC assay and it was revealed by the condensed chromatin and fragmented DNA. Compared with 5-FU or PT alone, the apoptosis of colorectal cancer cells treated with PT and 5-FU enhanced the activation of caspase-8, caspase-3. Conclusions: Combined treatment with PT may offer an efficacious strategy to overcome 5-FU resistance in certain CRC cells. (Intest Res 2012;10:357-364)

Citations

Citations to this article as recorded by  
  • Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
    Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
    Intestinal Research.2015; 13(3): 233.     CrossRef
  • 3,019 View
  • 32 Download
  • 1 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP